These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 3873489

  • 1. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM, Richman DP.
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [Abstract] [Full Text] [Related]

  • 2. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E, Klinkert WE, Wekerle H.
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [Abstract] [Full Text] [Related]

  • 3. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S, Galin FS, Kishimoto M, Adachi A, Blalock JB.
    J Immunol; 1996 Jul 01; 157(1):386-92. PubMed ID: 8683141
    [Abstract] [Full Text] [Related]

  • 4. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T, Yeh TM, Krolick KA.
    J Immunol; 1991 Jan 15; 146(2):663-70. PubMed ID: 1987281
    [Abstract] [Full Text] [Related]

  • 5. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL, Richman DP, Agius MA, Wollmann RL.
    J Immunol; 1987 May 15; 138(10):3269-75. PubMed ID: 3494763
    [Abstract] [Full Text] [Related]

  • 6. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y, Meng F, Vincent A, van Breda Vriesman P, de Baets M.
    J Immunol; 1995 Jun 15; 154(12):6382-96. PubMed ID: 7539019
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M, Donnelly-Roberts D, Richman DP, Martinez-Carrion M.
    J Immunol; 1994 Jun 15; 152(12):5997-6002. PubMed ID: 8207224
    [Abstract] [Full Text] [Related]

  • 8. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G, Tarrab-Hazdai R, Teichberg VI.
    Eur J Immunol; 1983 Jun 15; 13(6):500-7. PubMed ID: 6861875
    [Abstract] [Full Text] [Related]

  • 9. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
    Martinez RD, Tarrab-Hazdai R, Aharonov A, Fuchs S.
    J Immunol; 1977 Jan 15; 118(1):17-20. PubMed ID: 830746
    [Abstract] [Full Text] [Related]

  • 10. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
    Krolick KA, Yeh TM, Edlund SA.
    Cell Immunol; 1996 Aug 25; 172(1):10-20. PubMed ID: 8806801
    [Abstract] [Full Text] [Related]

  • 11. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
    Loutrari H, Kokla A, Tzartos SJ.
    Eur J Immunol; 1992 Sep 25; 22(9):2449-52. PubMed ID: 1516631
    [Abstract] [Full Text] [Related]

  • 12. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
    Agius MA, Richman DP.
    J Immunol; 1986 Oct 01; 137(7):2195-8. PubMed ID: 3489757
    [Abstract] [Full Text] [Related]

  • 13. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ, Spaans F, De Baets MH.
    Muscle Nerve; 1990 Jun 01; 13(6):485-92. PubMed ID: 2366822
    [Abstract] [Full Text] [Related]

  • 14. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.
    Saoudi A, Bernard I, Hoedemaekers A, Cautain B, Martinez K, Druet P, De Baets M, Guéry JC.
    J Immunol; 1999 Jun 15; 162(12):7189-97. PubMed ID: 10358165
    [Abstract] [Full Text] [Related]

  • 15. [Antibodies in myasthenia gravis].
    Eymard B.
    Rev Neurol (Paris); 2009 Feb 15; 165(2):137-43. PubMed ID: 19162288
    [Abstract] [Full Text] [Related]

  • 16. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
    Chen SM.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct 15; 23(5):293-6, 320. PubMed ID: 2282884
    [Abstract] [Full Text] [Related]

  • 17. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov 15; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 18. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ, Oshima M, Deitiker P.
    Crit Rev Immunol; 2001 Nov 15; 21(1-3):1-27. PubMed ID: 11642597
    [Abstract] [Full Text] [Related]

  • 19. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A, De Baets MH, Tzartos SJ, Lindstrom JM, Weigle WO, Theophilopoulos AN.
    Clin Exp Immunol; 1984 Jul 15; 57(1):41-50. PubMed ID: 6611231
    [Abstract] [Full Text] [Related]

  • 20. Combined short-term immunotherapy for experimental autoimmune myasthenia gravis.
    Pestronk A, Drachman DB, Teoh R, Adams RN.
    Ann Neurol; 1983 Aug 15; 14(2):235-41. PubMed ID: 6354071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.